What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.08%Below 5Y avg (0.33%)
Annual Rate
CNY 0.03Paid annual
Payout Ratio
19.3%Sustainable
Last Ex-Dividend
Jun 25, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.00BCNY
1.05B · vs all stocks (USD)
Updated Sep 22, 2026
Revenue (TTM)
511.80MCNY
76.43M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
-4.70%
Updated Sep 22, 2026
Beta
0.6990x
vs all stocks
Updated Sep 22, 2026
52-Week Change
-57.45%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
7.00BCNY
1.05B · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
7.09BCNY
1.06B · vs all stocks (USD)
Updated Sep 22, 2026
Forward P/E
38.59x
Updated Sep 22, 2026
Price to Sales (TTM)
13.76x
Updated Sep 22, 2026
Price to Book (MRQ)
6.49x
Updated Sep 22, 2026
Enterprise to Revenue
13.86x
Updated Sep 22, 2026
Gross Margin
26.26%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 29.04%.Updated Sep 22, 2026
Profit Margin
-4.70%
Updated Sep 22, 2026
Operating Margin
1.17%
Updated Sep 22, 2026
Return on Assets (TTM)
-0.15%
Updated Sep 22, 2026
Return on Equity (TTM)
-3.60%
Updated Sep 22, 2026
Revenue (TTM)
511.80MCNY
76.43M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
2.92CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
9.13%
Updated Sep 22, 2026
Gross Profit (TTM)
148.65MCNY
22.20M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
160.62MCNY
23.99M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
-24.03MCNY
-3.59M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
0.03%
Updated Sep 22, 2026
Operating Cash Flow (TTM)
-8.75MCNY
-1.31M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-118.89MCNY
-17.75M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.0300CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
0.08%
vs all stocks
Updated Sep 22, 2026
5-Year Average Dividend Yield
0.33%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
19.26%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -21.43%.Updated Sep 22, 2026
Minority Interest (Equity)
94.63MCNYFY2025 · Dec 31, 2025
Revenue
502.85MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
345.69MCNYFY2025 · Dec 31, 2025
Gross Profit
157.16MCNYFY2025 · Dec 31, 2025
Operating Income
31.51MCNY
4.71M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
85.39MCNYFY2025 · Dec 31, 2025
Income Tax Expense
7.99MCNYFY2025 · Dec 31, 2025
Net Income
77.40MCNYFY2025 · Dec 31, 2025
EBIT
96.91MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
160.62MCNYFY2025 · Dec 31, 2025
Research & Development
34.31MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
30.40MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.62MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
7.93MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
11.52MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5127CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5127CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
175.47MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
175.47MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
77.40MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
12.56MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
91.35MCNYFY2025 · Dec 31, 2025
Free Cash Flow
26.09MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
312.13MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
77.40MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
12.28MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
16.71MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-15.04MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-65.26MCNYFY2025 · Dec 31, 2025
Net Acquisitions
30.46MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-40.13MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.56MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-73.36MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
408.41MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-290.15MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-25.21MCNYFY2025 · Dec 31, 2025
Other Financing Charges
81.78MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
174.82MCNYFY2025 · Dec 31, 2025
Shares Outstanding
175.48MSharesUpdated Sep 22, 2026
Float Shares
90.28MSharesUpdated Sep 22, 2026
% Held by Insiders
48.08%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
7.92%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
486.99MCNY
72.72M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
2.77CNYUpdated Sep 22, 2026
Total Debt (MRQ)
450.86MCNY
67.33M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.3847x
Updated Sep 22, 2026
Current Ratio (MRQ)
2.14x
Updated Sep 22, 2026
Book Value per Share (MRQ)
6.19CNYUpdated Sep 22, 2026
Total Assets
1.91BCNY
285.63M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.14BCNYFY2025 · Dec 31, 2025
Total Liabilities
719.70MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
773.88MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
168.82MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
550.88MCNYFY2025 · Dec 31, 2025
Cash
323.08MCNYFY2025 · Dec 31, 2025
Cash Equivalents
7.73MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
330.81MCNYFY2025 · Dec 31, 2025
Accounts Receivable
327.92MCNYFY2025 · Dec 31, 2025
Inventory
116.88MCNYFY2025 · Dec 31, 2025
Accounts Payable
172.89MCNYFY2025 · Dec 31, 2025
Short-term Debt
297.54MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
10.94MCNYFY2025 · Dec 31, 2025
Long-term Debt
154.29MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.75MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
175.48MCNYFY2025 · Dec 31, 2025
Retained Earnings
456.61MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.19BCNY
178.16M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
30.85CNYUpdated Sep 22, 2026
52-Week High
99.87CNYUpdated Sep 22, 2026
52-Week Change
-57.45%
vs all stocks
Updated Sep 22, 2026
Beta
0.6990x
vs all stocks
Updated Sep 22, 2026
50-Day MA
37.73CNYUpdated Sep 22, 2026
200-Day MA
57.90CNYUpdated Sep 22, 2026
Avg 10-Day Volume
8.61MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
8.90MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
-0.1400CNYUpdated Sep 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
High ROE With Large Non-Operating Gap and Elevated-Margin-With-Deceleration
Return on equity reads high, with a large gap between pretax and operating income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
High ROE With Large Non-Operating Gap and Elevated-Margin-With-DecelerationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
High ROE With Large Non-Operating Gap and Elevated-Margin-With-DecelerationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
High ROE With Large Non-Operating Gap and Elevated-Margin-With-DecelerationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated